Intravenous human immunoglobulin (pH4) (Hualan Biological Engineering)

静注人免疫球蛋白 (pH4)（华兰生物工程）

Report date: 2026/02/12 20:00:14

Base Information

Drug NameIntravenous human immunoglobulin (pH4) (Hualan Biological Engineering)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsX chain low immunoglobulinAgammaglobulinemiaPurpura, Thrombocytopenic, Idiopathic +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHualan Biological Engineering Inc
China Registration ClassN/A

Develop Information

Active CompaniesHualan Biological Engineering Inc
Inactive CompaniesHualan Biological Engineering Chongqing Co Ltd
Active IndicationsX chain low immunoglobulinAgammaglobulinemiaPurpura, Thrombocytopenic, Idiopathic +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA02
Related LinksN/A